Maze (MAZE) GC Courtney Phillips Exercises RSUs for 11,000 Shares

What Happened

• Courtney Phillips, General Counsel and Corporate Secretary of Maze Therapeutics (MAZE), had 11,000 restricted stock units (RSUs convert/derivative code M) convert into 11,000 shares of common stock on September 1, 2026. The conversion was recorded at $0.00 per share, so no cash was paid or received in the transaction. This reflects vesting/settlement of equity awards rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-09-01 (Form 4 filed 2026-09-03, which is within the typical 2‑business‑day reporting window).
• Reported entries: Acquired 11,000 shares @ $0.00 (conversion of derivative); Disposed 11,000 derivatives @ $0.00 (cancellation of the RSUs upon settlement).
• Shares owned after transaction: Not specified in the provided filing data.
• Relevant footnotes from the filing:
  • F1: Each RSU is a contingent right to one share on settlement.
  • F2: The award vests 1/2 on Sep 1, 2026 and 1/2 on Sep 1, 2027, subject to continued service.
  • F3: The RSUs do not expire; they vest or are cancelled before the vesting date.
• Transaction code M indicates exercise or conversion of a derivative/security-based award (RSU conversion in this case).

Context

• This was a vesting/settlement event (conversion of RSUs) rather than a market purchase or sale; it does not by itself indicate buying or selling sentiment. The filing shows no proceeds or cashless sale — the RSUs were converted into shares and the corresponding RSU interests were cancelled per the award terms.